|
Market Closed -
OTC Markets
03:59:40 2026-10-22 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.0250 USD | -21.88% |
|
-16.67% | -3.85% |
| May. 18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Nov. 17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -21.88% | -16.67% | -6.02% | -16.67% | -3.85% | -48.56% | -95.58% | -99.53% | -99.52% | 8.48M | |
| +2.83% | +8.10% | +12.17% | +11.17% | +21.59% | +63.42% | +123.50% | +441.81% | +1,569.89% | 1,133B | |
| +3.81% | +5.40% | -0.69% | +6.78% | +29.31% | +39.47% | +74.91% | +63.78% | +135.90% | 621B | |
| +0.14% | +0.60% | +7.83% | +11.36% | +24.82% | +23.25% | +95.03% | +162.22% | +367.68% | 503B | |
| +0.03% | +5.72% | +7.48% | +17.47% | +19.47% | +39.64% | +64.06% | +9.59% | +68.79% | 379B | |
| -1.76% | -0.09% | -1.51% | +16.62% | +39.88% | +68.04% | +43.41% | +81.40% | +140.59% | 370B | |
| +1.58% | +5.07% | +10.97% | +2.66% | +17.59% | +23.26% | +51.98% | +66.19% | +72.07% | 292B | |
| +2.90% | +5.53% | +3.34% | +3.91% | -5.87% | +4.06% | +24.45% | +46.45% | +162.12% | 262B | |
| +2.04% | +4.97% | +13.77% | +22.13% | +36.65% | +48.53% | +60.42% | +114.02% | +182.18% | 237B | |
| +2.36% | +2.38% | +4.40% | +20.66% | +28.07% | +26.68% | +102.04% | +134.65% | +111.59% | 190B | |
| +1.17% | +3.44% | +1.83% | -18.30% | -18.60% | -25.41% | -60.93% | -20.72% | +86.71% | 174B | |
| +1.91% | +4.14% | +9.66% | +21.97% | +22.17% | +22.41% | -0.75% | -29.02% | -5.47% | 170B | |
| +2.03% | +7.36% | +4.79% | +11.03% | +18.05% | +25.55% | +47.89% | +186.05% | +562.67% | 133B | |
| +3.08% | +6.28% | +0.61% | +3.40% | +16.80% | +41.45% | +11.58% | +8.98% | +25.95% | 125B | |
| -0.31% | +3.66% | +14.20% | +22.14% | +23.41% | +28.59% | +123.57% | +388.60% | +528.67% | 118B | |
| +2.46% | +5.40% | +0.16% | +1.11% | +4.91% | +16.32% | +30.92% | +8.53% | -7.68% | 100B | |
| +1.88% | +4.36% | +0.48% | -2.35% | -9.39% | -13.14% | -24.16% | -10.72% | +8.31% | 98.91B | |
| -17.57% | -10.46% | +17.17% | +239.64% | +587.11% | +637.10% | +152.03% | -40.33% | - | 98.14B | |
| +1.67% | +5.23% | +2.62% | +21.31% | +6.12% | +41.38% | +1.31% | +43.86% | +125.32% | 80.45B | |
| +2.88% | +3.14% | +10.37% | +9.01% | +19.37% | +27.48% | -1.65% | -28.05% | +48.19% | 69.41B | |
| Average | +0.02% | +3.50% | +5.68% | +20.25% | +43.88% | +54.48% | +41.20% | +76.39% | +214.94% | 257.77B | |
| Weighted average by Cap. | +1.25% | +3.66% | +6.75% | +14.96% | +31.37% | +48.91% | +69.31% | +155.25% | +478.92% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
